Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Jul-24 5:37 PM View:  | Enliven Therapeutics, Inc. (ELVN) | 16-Jul-24 | Sale (Planned) | 1,547 | $25.01 | $38,692.20 | (< 1%) 345.57K to 344.03K | |
| 16-Jul-24 5:37 PM View: | Enliven Therapeutics, Inc. (ELVN) | 15-Jul-24 | Sale (Planned) | 30,978 | $25.05 | $776,039.00 | (8%) 376.55K to 345.57K | |
| 16-Jul-24 5:37 PM View: | Enliven Therapeutics, Inc. (ELVN) | 12-Jul-24 | Private Sale (Planned) | 17,475 | $25.07 | $438,095.00 | (4%) 394.03K to 376.55K | |
| 10-Jun-24 6:46 PM View: | Enliven Therapeutics, Inc. (ELVN) | 06-Jun-24 | Option Exercise | 1,133 | $2.48 | $2,809.84 | < 1% 394.03K to 395.16K | |
| 10-Jun-24 6:46 PM View: | Enliven Therapeutics, Inc. (ELVN) | 06-Jun-24 | Planned Option Sale | 1,133 | $20.06 | $22,722.40 | (< 1%) 395.16K to 394.03K | |
| 16-May-24 7:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 14-May-24 | Option Exercise | 1,107 | $2.48 | $2,745.36 | < 1% 394.03K to 395.13K | |
| 16-May-24 7:29 PM View: | Enliven Therapeutics, Inc. (ELVN) | 14-May-24 | Planned Option Sale | 1,107 | $25.00 | $27,675.00 | (< 1%) 395.13K to 394.03K | |
| 13-May-24 7:35 PM View: | Enliven Therapeutics, Inc. (ELVN) | 09-May-24 | Option Exercise | 260 | $2.48 | $644.80 | < 1% 394.03K to 394.29K | |
| 13-May-24 7:35 PM View: | Enliven Therapeutics, Inc. (ELVN) | 09-May-24 | Planned Option Sale | 260 | $25.06 | $6,515.50 | (< 1%) 394.29K to 394.03K | |
| 08-May-24 8:40 PM View: | Enliven Therapeutics, Inc. (ELVN) | 06-May-24 | Option Exercise | 4,875 | $2.48 | $12,090.00 | 1% 394.03K to 398.9K | |
| 08-May-24 8:40 PM View: | Enliven Therapeutics, Inc. (ELVN) | 06-May-24 | Planned Option Sale | 4,875 | $22.72 | $110,769.00 | (1%) 398.9K to 394.03K | |
| 15-Apr-24 7:06 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Option Exercise | 14,903 | $2.48 | $36,959.40 | 4% 396.62K to 411.53K | |
| 15-Apr-24 7:06 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Planned Option Sale | 14,903 | $25.03 | $373,085.00 | (4%) 411.53K to 396.62K | |
| 15-Apr-24 7:06 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Sale (Planned) | 2,597 | $25.03 | $65,013.80 | (< 1%) 396.62K to 394.03K | |
| 10-Apr-24 8:35 PM View: | Enliven Therapeutics, Inc. (ELVN) | 08-Apr-24 | Private Sale (Planned) | 4,875 | $18.60 | $90,686.80 | (1%) 401.5K to 396.62K | |
| 08-Mar-24 7:52 PM View: | Enliven Therapeutics, Inc. (ELVN) | 06-Mar-24 | Private Sale (Planned) | 4,875 | $15.64 | $76,238.70 | (1%) 406.37K to 401.5K | |
| 08-Feb-24 8:47 PM View: | Enliven Therapeutics, Inc. (ELVN) | 06-Feb-24 | Private Sale (Planned) | 4,875 | $15.11 | $73,658.30 | (1%) 411.25K to 406.37K | |
| 24-Jan-24 6:38 PM View: | Enliven Therapeutics, Inc. (ELVN) | 22-Jan-24 | Private Sale (Planned) | 4,875 | $15.14 | $73,783.10 | (1%) 416.12K to 411.25K | |
| 02-Jan-24 8:00 PM View: | Enliven Therapeutics, Inc. (ELVN) | 02-Jan-24 | Sale (Planned) | 11,000 | $15.00 | $165,053.00 | (3%) 427.12K to 416.12K | |
| 02-Jan-24 8:00 PM View: | Enliven Therapeutics, Inc. (ELVN) | 29-Dec-23 | Sale (Planned) | 20 | $15.00 | $300.00 | (< 1%) 427.14K to 427.12K | |
| 02-Jan-24 8:00 PM View: | Enliven Therapeutics, Inc. (ELVN) | 28-Dec-23 | Private Sale (Planned) | 2,520 | $15.08 | $37,995.60 | (< 1%) 429.66K to 427.14K | |
| 27-Dec-23 5:28 PM View: | Enliven Therapeutics, Inc. (ELVN) | 26-Dec-23 | Sale (Planned) | 102 | $15.01 | $1,530.51 | (< 1%) 429.77K to 429.66K | |
| 27-Dec-23 5:28 PM View: | Enliven Therapeutics, Inc. (ELVN) | 22-Dec-23 | Private Sale (Planned) | 983 | $15.03 | $14,775.80 | (< 1%) 430.75K to 429.77K | |
| 27-Feb-23 9:35 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-23 | Grant | 36,722 | -- | -- | 100% 0 to 36.72K | |
| 27-Feb-23 9:35 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-23 | Grant | 394,027 | -- | -- | 1073% 36.72K to 430.75K |